By enabling earlier detection and treatment of heart failure risk, Vivio® helps reduce avoidable hospitalizations, emergency department visits, and downstream costs associated with late-stage disease.  A positive Vivio test – coupled with appropriate chart documentation – allows for the submission of ICD-10 I50.1 which continues to map to HCC 226 under the current CMS RAF-HCC v28 model.